Seminars 2012

 

Marco Scarselli – Università di Pisa, Italia
9 febbraio 2012: “Recettori accoppiati a Proteine G:struttura-attività e microscopia di singole molecole”

Tatsuo Ushiki – School of Medical and Dental Sciences, Niigata, Giappone
29 maggio 2012 – “Stereoscanning electron microscopy of cells and tissues”

Joseph Sergeant – Vrije Universiteit, Amsterdam NL
30 Maggio 2012 – The Neurobiology of Emotion Dysregulation

Marco Sassoe’ Pognetto – Universita’ di Torino, Italia
19 Giugno 2012 – “Eterogeneita’ Molecolare delle Sinapsi GABAergiche”

Antonello Novelli – University of Oviedo, Spain
31 Maggio 2012 – Fundamentals of neuropsychology: from hystory to present
4 giugno 2012 – The components of behaviour: individual and social aspects – cognitive behaviour
5 giugno 2012 – The components of behaviour: individual and social aspects – emotional behaviour
6 giugno 2012 – The components of behaviour: individual and social aspects – executive behaviour
7 giugno 2012 – The components of behaviour: Future perspectives

Steven R. Laviolette – The Schulich School of Medicine
University of Western Ontario
02 luglio 2012 – “The Role of Cortical and Sub-Cortical Interactions controlling Opiate Addiction Related Memory”

George Panagis – University of Crete, Greece
03 luglio 2012 – “Modelling mania with intracranial self-stimulation: effects of mood stabilizers”

Cristina A Ghiani – University of California at Los Angeles, USA
4 Luglio 2012 – “Neuroglia, the other brain cells. Morphology, development and some physiology (An introduction)”
6 Luglio 2012 – “Glia and Disease (Leukodistrophies)”
10 Luglio 2012 – “Glia and Disease (HIV-HAD, AD, PD)”
12 Luglio  2012 – “NeuroInflammation”

Giovanni Marsicano – INSERM Université Bordeaux, France
19 luglio 2012 – “Astroglial CB1 cannabinoid receptors in memory”
24 luglio 2012 – “Mitochondrial CB1  receptors in the brain”

Michael A. Schwarzschild – Massachusetts General Institute for Neurodegenerative Disease, USA
05 luglio 2012 – “Epidemiology of Parkinson’s and other neurodegenerative diseases: environmental and dietary risk factors”.
06 luglio 2012 – “Current pharmacotherapy for the motor symptoms of PD targeting dopamine and other neurotransmitters: therapeutic and adverse actions and interactions in the clinic”
09 luglio 2012 – “Current pharmacotherapy for the non-motor symptoms of PD”
11 luglio 2012 – “Emerging non-dopaminergic drug therapies for parkinsonian symptoms”
13 luglio 2012 – “Emerging disease-modifying therapies for Parkinson’s disease: Challenges in moving neuroprotectants from the lab to the clinic”

Andrew J Lawrence – University of Melbourne, Australia
19 luglio 2012 – “Neuropeptides & reward-seeking”

Loren Parsons – The Scripps Research Institute,La Jolla, California USA
30 Luglio 2012 – “Preclinical evaluation of impaired cognitive function in drug dependence and protracted withdrawal”

 Scritto da alle 11:03
credits unica.it | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar